AVADEL PHARMACEUTICALS PLC (NASDAQ:AVDL) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

AVADEL PHARMACEUTICALS PLC (NASDAQ:AVDL) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02

On June 30, 2019, David P. Gusky resigned from his position as the Corporate Controller & Chief Accounting Officer of Avadel Pharmaceuticals plc (the “Company”) and from all other positions he holds with the Company and each of its subsidiaries. In his capacity as Corporate Controller and Chief Accounting Officer, Mr. Gusky had served as the Company’s principal accounting officer. Mr. Gusky’s resignation is not the result of any dispute or disagreement with the Company. Upon Mr. Gusky’s resignation, Michael F. Kanan, the Company’s Senior Vice President, Chief Financial Officer, and principal financial officer, assumed the responsibilities of principal accounting officer.

 

An ad to help with our costs